Hip Fracture

  Discuss the following: The patient is a 71-year-old widowed man who is seen regularly in the clinic for health maintenance and follow-up of his chronic insomnia and anxiety. He has regular prescriptions for triazolam (Halcion) and clonazepam (Klonopin) for these problems. Recently he has been reporting frequent episodes of losing his balance and falling, and eight weeks ago was hospitalized for a hip fracture sustained during one of these falls resulting in hip surgery. On this visit, he also complains of becoming increasingly confused. What information would be most critical for you to collect in the first visit? What is the primary goal for the treatment of this patient? Identify potential obstacles for change. Which educational approach would the PMHNP provide to overcome these obstacles? How would you teach the patient about the Beers list and Halcion? Discuss a medication in detail that could be safely substituted to treat insomnia in geriatric patients. Submission Instructions: Your initial post should be at least 500 words, formatted and cited in current APA style. Provide support for your work from at least 2 academic sources less than 5 years old.
The Importance of Collecting Critical Information In the first visit with the 71-year-old widowed man, it is crucial to gather specific information to adequately assess his current condition and plan an appropriate course of treatment. The following information would be most critical to collect during this initial visit: Comprehensive Medical History: Understanding the patient’s medical history is essential to identify any underlying conditions or previous events that may contribute to his current symptoms. This would involve exploring his past medical diagnoses, surgeries, and hospitalizations, as well as any relevant family history. Medication History: Thoroughly reviewing the patient’s medication history is crucial to identify any potential medication-related issues that may contribute to his symptoms. This includes assessing the dosage, frequency, and duration of current medications, as well as any recent changes in his medication regimen. Fall Assessment: Gathering detailed information about the frequency, circumstances, and characteristics of his falls is essential to assess his risk of falling. This would involve asking about the location, time of day, and activities preceding the falls, as well as any associated symptoms such as dizziness or loss of consciousness. Cognitive Assessment: Given the patient’s complaint of increasing confusion, a comprehensive cognitive assessment should be conducted to evaluate his cognitive functioning. This may involve using standardized cognitive screening tools to assess memory, attention, executive functioning, and other cognitive domains. Sleep Assessment: Evaluating the patient’s sleep patterns and quality is crucial to address his chronic insomnia. This may involve asking about the duration and quality of sleep, any difficulties falling asleep or staying asleep, and any daytime consequences such as daytime sleepiness or fatigue. Primary Goal for Treatment The primary goal for the treatment of this patient should be to improve his overall quality of life by addressing his chronic insomnia, anxiety, balance issues, and cognitive changes. The treatment plan should aim to reduce the frequency of falls, alleviate confusion, and improve sleep quality and duration. Additionally, it is important to minimize any potential adverse effects of medications and optimize the patient’s safety and well-being. Identifying Potential Obstacles for Change There are several potential obstacles that may hinder the patient’s progress towards improved health and well-being: Medication-related issues: The patient is currently prescribed triazolam (Halcion) and clonazepam (Klonopin), which are listed on the Beers Criteria, a list of potentially inappropriate medications for older adults. Educating the patient about the risks associated with these medications and the need for alternative treatments may be challenging. Resistance to Change: The patient may be resistant to change or skeptical about trying new medications or treatment approaches. Addressing any concerns or misconceptions and providing clear explanations about the potential benefits and risks of alternative medications is essential. Limited Social Support: Being a widowed individual, the patient may have limited social support, which can impact his ability to adhere to treatment recommendations or engage in lifestyle modifications. Identifying and addressing any barriers to social support is crucial for the patient’s overall well-being. To overcome these obstacles, the PMHNP would employ an educational approach that includes the following strategies: Patient-Centered Approach: The PMHNP should engage in open and empathetic communication with the patient, allowing him to express his concerns, fears, and preferences. This approach helps build trust and facilitates a collaborative decision-making process. Clear Explanation of Risks and Benefits: The PMHNP should provide the patient with clear and concise information about the risks associated with the medications listed on the Beers Criteria, emphasizing the potential harm they may cause. Additionally, the PMHNP should discuss the benefits of alternative medications and treatment options, highlighting their potential to improve sleep, reduce falls, and alleviate confusion. Involvement of Caregivers: If available, involving caregivers or family members in the educational process can help reinforce the importance of treatment adherence and provide additional support to the patient. Caregivers can play an active role in monitoring the patient’s medication regimen and assisting with lifestyle modifications. Teaching the Patient about the Beers List and Halcion The Beers List is a list of medications that are potentially inappropriate for older adults due to their increased risk of adverse effects. Halcion (triazolam) is one of the medications listed on the Beers Criteria. When teaching the patient about the Beers List and Halcion, the following points should be addressed: Explanation of the Beers List: The PMHNP should explain that the Beers List is a tool developed by experts to identify medications that may pose risks to older adults. It is important to emphasize that the list is not a strict prohibition but rather a guide to help healthcare professionals make informed decisions about medication use in older adults. Risks Associated with Halcion: The PMHNP should explain that Halcion (triazolam) is a medication commonly prescribed for insomnia but has been associated with an increased risk of falls, confusion, and cognitive impairment in older adults. It is crucial to highlight the potential harm that Halcion may pose, particularly in the context of the patient’s recent falls and increasing confusion. Alternative Treatment Options: The PMHNP should discuss alternative treatment options for insomnia that are considered safer for older adults. This may include non-pharmacological interventions such as sleep hygiene practices, cognitive-behavioral therapy for insomnia (CBT-I), and relaxation techniques. If necessary, the PMHNP may also consider prescribing a safer medication for insomnia, such as a low-dose sedating antidepressant or a non-benzodiazepine hypnotic. Safe Medication Substitution for Insomnia in Geriatric Patients One medication that could be safely substituted to treat insomnia in geriatric patients is low-dose trazodone. Trazodone is an antidepressant that has sedating properties and is commonly used off-label for the treatment of insomnia. Benefits of using low-dose trazodone for insomnia in geriatric patients include: Safety: Trazodone is generally well-tolerated in older adults and has a lower risk of adverse effects compared to benzodiazepines or benzodiazepine receptor agonists. Sedating Effects: Trazodone’s sedating properties can help improve sleep initiation and maintenance without causing significant next-day cognitive impairment or daytime sleepiness. Antidepressant Effect: If the patient has comorbid depression or anxiety, trazodone can provide dual benefits by treating both insomnia and mood symptoms. It is important to note that when prescribing trazodone, the PMHNP should start with a low dose and titrate gradually to minimize the risk of adverse effects such as orthostatic hypotension or priapism. Additionally, regular monitoring of the patient’s response and side effects is essential to ensure optimal treatment outcomes. In summary, when working with the 71-year-old widowed man, it is crucial to collect critical information during the first visit, including a comprehensive medical history, medication history, fall assessment, cognitive assessment, and sleep assessment. The primary goal for treatment should be to improve the patient’s overall quality of life. Potential obstacles, such as medication-related issues and resistance to change, can be overcome through a patient-centered approach, clear explanation of risks and benefits, and involvement of caregivers. Educating the patient about the Beers List and Halcion should focus on explaining the purpose of the list, the risks associated with Halcion, and alternative treatment options. Finally, low-dose trazodone can be considered as a safe medication substitution for treating insomnia in geriatric patients.    

Sample Answer